ID

34470

Description

Effectiveness of Conversion to Sirolimus Versus Calcineurin Inhibitor (CNI) Reduction in Renal Transplant Patients With Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00922129

Lien

https://clinicaltrials.gov/show/NCT00922129

Mots-clés

  1. 17/01/2019 17/01/2019 -
  2. 27/05/2019 27/05/2019 -
  3. 29/05/2019 29/05/2019 -
Détendeur de droits

see on clinicaltrials.gov

Téléchargé le

17 janvier 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Prostate Cancer NCT00922129

Eligibility Prostate Cancer NCT00922129

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
male patients ≤ 50 years in their post renal transplant follow-up;
Description

ID.1

Type de données

boolean

biopsy confirmed prostate cancer;
Description

ID.2

Type de données

boolean

stable renal function with gfr ≥ 40 ml/min.
Description

ID.3

Type de données

boolean

Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients with metastatic disease;
Description

ID.4

Type de données

boolean

uncontrolled hyperlipidemia;
Description

ID.5

Type de données

boolean

proteinuria > 500 mg/day;
Description

ID.6

Type de données

boolean

biopsy evidence of acute rejection within the past 3 months;
Description

ID.7

Type de données

boolean

existence of any surgical or medical condition, other than the current transplant, which in the opinion of the investigator might significantly alter the absorption, distribution, metabolism or excretion of study medication;
Description

ID.8

Type de données

boolean

patients with mental illness;
Description

ID.9

Type de données

boolean

inability to cooperate or communicate with the investigator or unable to complete self administered questionnaires.
Description

ID.10

Type de données

boolean

Similar models

Eligibility Prostate Cancer NCT00922129

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
male patients ≤ 50 years in their post renal transplant follow-up;
boolean
ID.2
Item
biopsy confirmed prostate cancer;
boolean
ID.3
Item
stable renal function with gfr ≥ 40 ml/min.
boolean
Item Group
C0680251 (UMLS CUI)
ID.4
Item
patients with metastatic disease;
boolean
ID.5
Item
uncontrolled hyperlipidemia;
boolean
ID.6
Item
proteinuria > 500 mg/day;
boolean
ID.7
Item
biopsy evidence of acute rejection within the past 3 months;
boolean
ID.8
Item
existence of any surgical or medical condition, other than the current transplant, which in the opinion of the investigator might significantly alter the absorption, distribution, metabolism or excretion of study medication;
boolean
ID.9
Item
patients with mental illness;
boolean
ID.10
Item
inability to cooperate or communicate with the investigator or unable to complete self administered questionnaires.
boolean

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial